Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Koeppen, Michael ^a   Eckle, Tobias ^a   Eltzschig, Holger K ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; XANTHINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRADYCARDIA; CAROTID ARTERY; CHRONOTROPISM; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG SELECTIVITY; DRUG TARGETING; GENE DELETION; GENOTYPE; HEART HEMODYNAMICS; HEART RATE; IN VIVO STUDY; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PHARMACOGENETICS; WILD TYPE; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; DRUG EFFECT; GENETICS; MOUSE MUTANT; PHYSIOLOGY;

MUS;

ADENOSINE; ANIMALS; BLOOD PRESSURE; HEART RATE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, ADENOSINE A1; XANTHINES;

EID: 69449097667     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006784     Document Type: Article

References (44)

1. Drury AN, Szent-Gyorgyi A (1929) The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68: 213-237.
2. Belhassen B, Pelleg A (1984) Electrophysiologic effects of adenosine triphosphate and adenosine on the mammalian heart: clinical and experimental aspects. J Am Coll Cardiol 4: 414-424.
3. Delacretaz E (2006) Clinical practice. Supraventricular tachycardia. N Engl J Med 354: 1039-1051.
4. Fredholm BB (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 14: 1315-1323.
5. West GA, Belardinelli L (1985) Correlation of sinus slowing and hyperpolarization caused by adenosine in sinus node. Pflugers Arch 403: 75-81.
6. Belardinelli L, Shryock JC, Song Y, Wang D, Srinivas M (1995) Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J 9: 359-365.
7. Belardinelli L, Giles WR, West A (1988) Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart. J Physiol 405: 615-633.
8. Olsson RA, Pearson JD (1990) Cardiovascular purinoceptors. Physiol Rev 70: 761-845.
9. Reichelt ME, Willems L, Molina JG, Sun CX, Noble JC, et al. (2005) Genetic deletion of the A1 adenosine receptor limits myocardial ischemic tolerance. Circ Res 96: 363-367.
10. Sun D, Samuelson LC, Yang T, Huang Y, Paliege A, et al. (2001) Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci U S A 98: 9983-9988.
11. Eckle T, Krahn T, Grenz A, Kohler D, Mittelbronn M, et al. (2007) Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115: 1581-1590.
12. Salvatore CA, Tilley SL, Latour AM, Fletcher DS, Koller BH, et al. (2000) Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem 275: 4429-4434.
13. Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, et al. (1997) Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388: 674-678.
14. Eckle T, Grenz A, Kohler D, Redel A, Falk M, et al. (2006) Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol 291: H2533-2540.
15. Koeppen M, Feil R, Siegl D, Feil S, Hofmann F, et al. (2004) cGMP-dependent protein kinase mediates NO- but not acetylcholine-induced dilations in resistance vessels in vivo. Hypertension 44: 952-955.
16. Siegl D, Koeppen M, Wolfle SE, Pohl U, de Wit C (2005) Myoendothelial coupling is not prominent in arterioles within the mouse cremaster microcirculation in vivo. Circ Res 97: 781-788.
17. Grenz A, Zhang H, Weingart J, von Wietersheim S, Eckle T, et al. (2007) Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia. Am J Physiol Renal Physiol 293: F1501-1511.
18. Eckle T, Kohler D, Lehmann R, El Kasmi KC, Eltzschig HK (2008) Hypoxia-Inducible Factor-1 Is Central to Cardioprotection: A New Paradigm for Ischemic Preconditioning. Circulation 118: 166-175.
19. Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-552.
20. Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, et al. (2001) Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci U S A 98: 9407-9412.
21. Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, et al. (2004) Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annual Review of Immunology 22: 657-682.
22. Eltzschig HK, Ibla JC, Furuta GT, Leonard MO, Jacobson KA, et al. (2003) Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198: 783-796.
23. Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, et al. (2009) Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 10: 195-202.
24. Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, et al. (2008) A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111: 2024-2035.
25. Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, et al. (2005) HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202: 1493-1505.
26. Eckle T, Grenz A, Laucher S, Eltzschig HK (2008) A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 118: 3301-3315.
27. Ohta A, Sitkovsky M (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920.
28. Sitkovsky M, Lukashev D (2005) Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 5: 712-721.
29. Huang ZL, Qu WM, Eguchi N, Chen JF, Schwarzschild MA, et al. (2005) Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci 8: 858-859.
30. Yang JN, Chen JF, Fredholm BB (2009) Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine. Am J Physiol Heart Circ Physiol 296: H1141-1149.
31. Yang JN, Tiselius C, Dare E, Johansson B, Valen G, et al. (2007) Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A1 receptors. Acta Physiol (Oxf) 190: 63-75.
32. Rivkees SA, Chen M, Kulkarni J, Browne J, Zhao Z (1999) Characterization of the murine A1 adenosine receptor promoter, potent regulation by GATA-4 and Nkx2.5. J Biol Chem 274: 14204-14209.
33. Linden J, Hollen CE, Patel A (1985) The mechanism by which adenosine and cholinergic agents reduce contractility in rat myocardium. Correlation with cyclic adenosine monophosphate and receptor densities. Circ Res 56: 728-735.
34. Kapicka CL, Montamat SC, Olson RD, Musser B, Mudumbi RV, et al. (2003) Species comparison of adenosine A1 receptors in isolated mammalian atrial and ventricular myocardium. Life Sci 72: 2825-2838.
35. Hasko G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7: 759-770.
36. Headrick JP, Gauthier NS, Morrison RR, Matherne GP (2000) Chronotropic and vasodilatory responses to adenosine and isoproterenol in mouse heart: effects of adenosine A1 receptor overexpression. Clin Exp Pharmacol Physiol 27: 185-190.
37. Gauthier NS, Headrick JP, Matherne GP (1998) Myocardial function in the working mouse heart overexpressing cardiac A1 adenosine receptors. J Mol Cell Cardiol 30: 187-193.
38. Matherne GP, Linden J, Byford AM, Gauthier NS, Headrick JP (1997) Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci U S A 94: 6541-6546.
39. Bertolet BD, Eagle DA, Conti JB, Mills RM, Belardinelli L (1996) Bradycardia after heart transplantation: reversal with theophylline. J Am Coll Cardiol 28: 396-399.
40. Barraco RA, Janusz CJ, Polasek PM, Parizon M, Roberts PA (1988) Cardiovascular effects of microinjection of adenosine into the nucleus tractus solitarius. Brain Res Bull 20: 129-132.
41. Yilmaz MS, Coskun C, Suzer O, Yalcin M, Mutlu D, et al. (2008) Hypotensive effects of intravenously administered uridine and cytidine in conscious rats: involvement of adenosine receptors. Eur J Pharmacol 584: 125-136.
42. Thengchaisri N, Miriel VA, Rivers RJ (2009) Multiple receptor subtypes and multiple mechanisms of dilation are involved in vascular network dilation caused by adenosine. Microvasc Res 77: 356-363.
43. Nicholls J, Hourani SM, Hall JM (2002) Characterization of adenosine receptors mediating the vasodilator effects of adenosine receptor agonists in the microvasculature of the hamster cheek pouch in vivo. Auton Autacoid Pharmacol 22: 209-214.
44. Keddie JR, Poucher SM, Shaw GR, Brooks R, Collis MG (1996) In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist. Eur J Pharmacol 301: 107-113.